Bajaj HealthCare Intrinsic Value
Bajaj HealthCare (BAJAJHCARE) median intrinsic value is ₹187.43 from 8 valuation models (range ₹92–₹627), vs current price ₹307.05 — -39.0% downside (Trading Above Calculated Value), margin of safety -63.8%. Browse BAJAJHCARE financial statements for revenue, profit, balance sheet and cash flow data.
BAJAJHCARE Valuation Methods Summary — DCF, Graham Number & P/E
Bajaj HealthCare intrinsic value across 8 models vs current price ₹307.05 — upside/downside and value range per method. Also explore BAJAJHCARE share price data to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹109.56 | ₹87.65 - ₹131.47 | -64.3% | EPS: ₹4.98, Sector P/E: 22x |
| Book Value Method | asset | ₹627.06 | ₹564.35 - ₹689.77 | +104.2% | Book Value/Share: ₹313.53, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹614.10 | ₹552.69 - ₹675.51 | +100.0% | Revenue/Share: ₹359.41, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹388.24 | ₹349.42 - ₹427.06 | +26.4% | EBITDA: ₹66.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹122.82 | ₹98.26 - ₹147.38 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹92.11 | ₹82.90 - ₹101.32 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹92.11 | ₹82.90 - ₹101.32 | -70.0% | Revenue Growth: -2.7%, Adj P/E: 14.8x |
| Graham Defensive Method | conservative | ₹187.43 | ₹168.69 - ₹206.17 | -39.0% | EPS: ₹4.98, BVPS: ₹313.53 |
BAJAJHCARE Intrinsic Value vs Market Price — All Valuation Models
Bajaj HealthCare fair value range ₹92–₹627 vs current market price ₹307.05 across 8 valuation models. For current market price and key ratios, visit BAJAJHCARE share price screener.
BAJAJHCARE Intrinsic Value Analysis — Undervalued or Overvalued?
Bajaj HealthCare median intrinsic value ₹187.43, current price ₹307.05 — Trading Above Calculated Value by 39.0%, margin of safety -63.8%.
What is the intrinsic value of BAJAJHCARE?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Bajaj HealthCare (BAJAJHCARE) is ₹187.43 (median value). With the current market price of ₹307.05, this represents a -39.0% variance from our estimated fair value.
The valuation range spans from ₹92.11 to ₹627.06, indicating ₹92.11 - ₹627.06.
Is BAJAJHCARE undervalued or overvalued?
Based on our multi-method analysis, Bajaj HealthCare (BAJAJHCARE) appears to be trading above calculated value by approximately 39.0%.
BAJAJHCARE Financial Health — Key Ratios vs Industry Benchmarks
Bajaj HealthCare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 9.81 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 4.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 11.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.66x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
BAJAJHCARE Cash Flow Quality — Operating & Free Cash Flow
Bajaj HealthCare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹22 Cr | ₹15 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹92 Cr | ₹87 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-22 Cr | ₹-69 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹1 Cr | ₹-37 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹44 Cr | ₹-11 Cr | Positive Operating Cash Flow | 6/10 |